Frederick Tay
Frederick is with the firm’s corporate practice, specialising in mergers and acquisitions and corporate transactions. He has more than 10 years of experience in the healthcare and consumer healthcare industry.
In the healthcare and life sciences industry, Frederick has advised and implemented both operational and transactional solutions for companies which include advising on supply contracts for active pharmaceutical ingredients in the manufacturing process, pricing and supply of medicines contracts with both public and private healthcare practices, advising on cross-border transactions globally, and advising on digital projects.
Contact Information:
All Posts:
Commentary
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?
Do Singapore workplaces mistake silence for leadership?
AI as the new competitive advantage for Singapore’s small retailers
Singapore's next payments opportunity